Market closed

Klotho Neurosciences Inc/$KLTO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Klotho Neurosciences Inc

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

Ticker

$KLTO
Trading on

Industry

Biotechnology

Employees

3

ISIN

US49876K1034

KLTO Metrics

BasicAdvanced
$4.6M
-
-$0.32
0.02
-
$4.6M
0.02
$0.37
$0.11
176K
0.126
0.051
20.311
-15.54%
-148.93%
-700.07%
3.66
-3.89
-1.003
540.00%
267.33%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $KLTO

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Klotho Neurosciences Inc stock?

What is the P/E ratio for Klotho Neurosciences Inc stock?

Does Klotho Neurosciences Inc stock pay dividends?

When is the next Klotho Neurosciences Inc dividend payment date?

What is the beta indicator for Klotho Neurosciences Inc?